Medications for Alzheimer's disease are designed to alleviate symptoms and slow its progression. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine are frequently prescribed to enhance nerve cell communication and preserve cognitive function. Another class of drugs, memantine, regulates glutamate activity, crucial for memory and learning processes. While these medications don't cure Alzheimer's, they can help manage symptoms such as memory loss, confusion, and behavioral changes, potentially improving patients' quality of life. Due to varying responses and possible side effects, careful monitoring and adjustments are necessary. Ongoing research aims to develop new treatments that could alter the disease's course or provide more effective relief for individuals with Alzheimer's and related dementias.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States